SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
SRX Global Inc. has purchased senior secured debt in CERo Therapeutics Holdings, providing CERo with additional capital to accelerate clinical development of its engineered T cell therapeutic, CER-1236, which is currently in Phase 1 trials for multiple hematologic cancers. The investment supports CERo's strategy to advance innovative cancer immunot…